Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Core Viewpoint - Arcutis Biotherapeutics, Inc. will report its first quarter 2025 financial results and provide a business update on May 6, 2025, after U.S. financial markets close [1] Company Overview - Arcutis Biotherapeutics, Inc. is a commercial-stage medical dermatology company focused on innovations in immuno-dermatology, addressing the needs of individuals with immune-mediated dermatological diseases [3] - The company has a growing portfolio that includes three FDA-approved products and a robust pipeline targeting various inflammatory dermatological conditions such as scalp and body psoriasis, atopic dermatitis, and alopecia areata [3] Upcoming Events - A conference call and webcast will be held on May 6, 2025, at 4:30 p.m. ET, with a live webcast available on the company's website [2]